Ashfield

RSIP Vision | June 22, 2020

These innovative modules empower a wide range of medical applications by overcoming the main ultrasound challenges - user-dependent acquisition and noisy, clinically challenging images. This improves the workflow and diagnostic accuracy while reducing the overall procedure time.RSIP Vision, a global leader in artificial intelligence (AI) and computer vision technology, announced today a new set of AI-based medical ultrasound modules. These advanced modules will serve as AI-based building b...

Healthtech Security, Future of Healthcare

Included Health | February 13, 2023

Included Health, the first organization to fully integrate virtual care and navigation, recently announced that it would collaborate with Solv to advance the Included Health member experience to include suitable same-day in-person medical visits. The proposed service expansion will enhance Included Health's longitudinal support for members across the entire continuum of care. It will also complement the company's existing in-person care capabilities through its integrate...

Health Technology, Medical Devices

Masimo | March 10, 2023

Masimo, a pioneer in technology and automation solutions for the healthcare industry, and Temple Health, a leading academic health system in Philadelphia, recently announced the formation of a strategic innovation collaboration. With a focus on advancing the forefront of telehealth and remote patient monitoring and automating high-quality care, the strategic partnership may involve using innovations such as the Radius VSMTM tetherless multimodal patient monitor, Masimo W1TM...

MedCity News | January 15, 2020

Although it faced a setback earlier this month when regulators put the kibosh on its deal to acquire a rival company, genetic sequencing equipment maker Illumina will leave the J.P. Morgan Healthcare Conference with two new partnering deals under its belt. The San Diego-based company and Swiss drug and diagnostics maker Roche said Monday that they had formed a partnership to increase availability of genomic testing to patients with cancers. The 15-year, non-exclusive partnership is meant to broa...